+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bacterial Vaginosis Drugs Market by Drug Class, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Bacterial Vaginosis Drugs Market by Drug Class, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Bacterial Vaginosis Drugs Market by Drug Class, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013746
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bacterial Vaginosis Drugs Market is undergoing notable changes, as increased awareness and evolving treatment requirements drive a shift in how stakeholders respond to emerging therapeutic and operational challenges. Senior decision-makers require actionable insights to navigate this complex and expanding landscape effectively.

Market Snapshot: Bacterial Vaginosis Drugs Market

The Bacterial Vaginosis Drugs Market grew from USD 921.92 million in 2024 to USD 979.40 million in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 1.30 billion by 2030. This trajectory underscores the expanding demand for therapeutic solutions and the market's resilience in the face of regulatory and supply chain volatility.

Scope & Segmentation

This report delivers comprehensive segmentation and regional coverage to inform strategic planning and competitive positioning:

  • Drug Class: Antibiotics (clindamycin, metronidazole, tinidazole) and antiseptics.
  • Route of Administration: Oral and vaginal.
  • Dosage Form: Cream, gel, suppository, and tablets.
  • Distribution Channel: Hospital pharmacy, online pharmacy, retail pharmacy.
  • End User: Clinics, home healthcare, hospitals.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning major markets such as United Kingdom, Germany, France, Saudi Arabia, and South Africa), and Asia-Pacific (covering China, India, Japan, Australia, and Southeast Asia).
  • Key Companies: Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sandoz Inc., Viatris Inc., Dr. Reddy's Laboratories Ltd, Lupin Limited, Cipla Limited, Perrigo Company plc, Gedeon Richter Plc, Glenmark Pharmaceuticals Limited.

Advanced technologies featured within the scope include targeted antimicrobial peptides, novel drug delivery formats such as intravaginal rings and mucoadhesive gels, and digital health platforms supporting patient engagement and remote monitoring.

Key Takeaways for Senior Decision-Makers

  • The market is shaped by clinical innovation and evolving reimbursement structures, requiring alignment with patient needs and real-world effectiveness.
  • Leading therapeutics in bacterial vaginosis benefit from both established drug classes and a pipeline of differentiated delivery systems poised to address recurrence and adherence challenges.
  • Technological progress enables earlier diagnosis, with molecular diagnostics and biofilm-disrupting agents supporting tailored treatment approaches and improved patient outcomes.
  • Segment dynamics reveal that while antibiotics remain prominent, there is significant opportunity in adjunctive probiotic therapies, advanced local delivery systems, and patient-focused formulations.
  • Geographic variations reflect differing levels of healthcare infrastructure, reimbursement traditions, and patient awareness, providing multiple entry points for targeted strategies.

Tariff Impact on Bacterial Vaginosis Drug Supply Chains

Recent United States tariffs introduced in 2025 have created supply chain cost pressures, particularly affecting sourcing of active pharmaceutical ingredients. Companies have adapted through renegotiated supplier terms, vertical integration, and shifts toward domestic or low-tariff regions, with further impacts on inventory management and working capital allocation. These changes emphasize the need for agile procurement, supply chain risk mitigation, and continuous monitoring of the evolving trade environment.

Methodology & Data Sources

This analysis draws from structured interviews with pharmaceutical executives, clinicians, and payers, coupled with peer-reviewed literature and validated industry databases. Findings were triangulated to ensure robustness, with qualitative insights vetted by advisory committees and data integrity maintained through cross-verification and trend analysis. The methodology ensures that the insights reflect both the strategic and operational realities of the bacterial vaginosis therapeutics market.

Why This Report Matters

  • Enables executive teams to identify high-growth segments and prioritize investment based on validated market intelligence.
  • Supports strategic decision-making by mapping regulatory, technological, and regional drivers to operational realities.
  • Delivers actionable recommendations on tariff risk management, advanced drug delivery strategies, and differentiated market entry approaches.

Conclusion

The bacterial vaginosis therapeutics market is characterized by dynamic innovation, shifting reimbursement models, and complex supply chain demands. This report provides the essential insights and strategic context required for effective market navigation and future-ready planning.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bacterial Vaginosis Drugs Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Clindamycin
8.2.2. Metronidazole
8.2.3. Tinidazole
8.3. Antiseptics
9. Bacterial Vaginosis Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Vaginal
10. Bacterial Vaginosis Drugs Market, by Dosage Form
10.1. Introduction
10.2. Cream
10.3. Gel
10.4. Suppository
10.5. Tablets
11. Bacterial Vaginosis Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Bacterial Vaginosis Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
13. Americas Bacterial Vaginosis Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bacterial Vaginosis Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bacterial Vaginosis Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Pfizer Inc.
16.3.3. Sandoz Inc.
16.3.4. Viatris Inc.
16.3.5. Dr. Reddy's Laboratories Ltd
16.3.6. Lupin Limited
16.3.7. Cipla Limited
16.3.8. Perrigo Company plc
16.3.9. Gedeon Richter Plc
16.3.10. Glenmark Pharmaceuticals Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BACTERIAL VAGINOSIS DRUGS MARKET MULTI-CURRENCY
FIGURE 2. BACTERIAL VAGINOSIS DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. BACTERIAL VAGINOSIS DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BACTERIAL VAGINOSIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BACTERIAL VAGINOSIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BACTERIAL VAGINOSIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY CLINDAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY METRONIDAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY TINIDAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTISEPTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY VAGINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY SUPPOSITORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 44. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 45. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 47. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CANADA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 82. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 84. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. GERMANY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 88. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 100. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 102. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ITALY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 105. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 106. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. SPAIN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. DENMARK BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 142. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. QATAR BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 148. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 150. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. FINLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. EGYPT BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 172. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. TURKEY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 186. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NORWAY BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 190. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. POLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 207. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 208. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 209. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 211. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. CHINA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 214. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 215. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. INDIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 223. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. JAPAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BACTERIAL VAGINOSIS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. BACTERIAL VAGINOSIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 280. BACTERIAL VAGINOSIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bacterial Vaginosis Drugs market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sandoz Inc.
  • Viatris Inc.
  • Dr. Reddy's Laboratories Ltd
  • Lupin Limited
  • Cipla Limited
  • Perrigo Company plc
  • Gedeon Richter Plc
  • Glenmark Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 979.4 Million
Forecasted Market Value ( USD ) by 2030 $ 1300 Million
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bacterial Vaginosis Drug Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Dosage Form, Distribution Channel, and Geography - Product Image

Bacterial Vaginosis Drug Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Dosage Form, Distribution Channel, and Geography

  • Report
  • 184 Pages
  • Global
From
Bacterial Vaginosis - Pipeline Insight, 2025 - Product Image

Bacterial Vaginosis - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Pregnancy and Anti-Infective Agents - Product Image

Pregnancy and Anti-Infective Agents

  • Book
From
Acute Bacterial Skin & Skin Structure Infection Market by Product Type, Route Of Administration, End User, Distribution Channel, Treatment Type - Global Forecast to 2030 - Product Image

Acute Bacterial Skin & Skin Structure Infection Market by Product Type, Route Of Administration, End User, Distribution Channel, Treatment Type - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From

About the Bacterial Vaginosis Drug Market

Bacterial Vaginosis (BV) is a common vaginal infection caused by an imbalance of bacteria in the vagina. BV is typically treated with antibiotics, such as metronidazole, clindamycin, and tinidazole. These antibiotics are part of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. The Bacterial Vaginosis Drug market is a subset of the Infectious Diseases Drugs market, and is composed of antibiotics used to treat BV. These drugs are typically prescribed in the form of oral tablets, topical creams, and vaginal gels. Some companies in the Bacterial Vaginosis Drug market include Pfizer, Merck, GlaxoSmithKline, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.